返回成功案例
医疗健康

Bellefleur has been acquired by Domidep

Belgian nursing home Bellefleur has been sold to Domidep, one of France’s largest private nursing home operators.

Headquartered in Aubange, Belgium, Bellefleur owns and operates a state-of-the-art nursing home in the Luxembourg province. After the nursing home’s refurbishment and extension in 2022, Bellefleur operates 91 accredited beds, with a total capacity for 99 beds. Through its strategic location, a limited competitive landscape in the region and efficient management, Bellefleur has been able to achieve an occupancy rate of around 100% for long-term stays since 2022.

Founded in 1989, Domidep is a leading player in the healthcare sector, operating mainly medicalized nursing homes. On the strength of its roots and experience in France, with almost 120 establishments at the end of 2022 accommodating 7,700 residents, Domidep is now also expanding internationally. The company is already present in Germany and Belgium, with over 35 establishments for almost 2,900 residents.

Oaklins’ team in Belgium acted as the exclusive M&A sell-side advisor to Bellefleur in this transaction.

我们的服务
交易方

联系交易团队

Julien Wigny

总监
布鲁塞尔, 比利时
Oaklins KBC Securities

Laurent Wielfaert

高级经理
布鲁塞尔, 比利时
Oaklins KBC Securities

Jérôme Heinrich

经理
布鲁塞尔, 比利时
Oaklins KBC Securities

相关交易

Bayer AG has entered into a takeover agreement with Cara Care
医疗健康 | 科技、媒体及通讯

Bayer AG has entered into a takeover agreement with Cara Care

Bayer AG, renowned for its advancements in healthcare and life sciences, has finalized the acquisition of Cara Care (HiDoc Technologies GmbH), which entered debtor-in-possession proceedings in October 2024. Cara Care, an innovative digital health platform and official DiGA, aligns perfectly with Bayer’s strategic focus on digital health and the expansion of its innovative solutions portfolio. The transaction is expected to close in Spring 2025.

更多信息
Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.
医疗健康

Vivo Diagnóstico has been acquired by NEXXUS-IBERIA SGEIC, S.A.

NEXXUS-IBERIA SGEIC, S.A. a private equity firm in Spain, has completed its acquisition of a majority stake in Vivo Diagnóstico. With this financial backing from NEXXUS-IBERIA, Vivo will focus on inorganic growth as well as investing in service quality, innovation and efficiency.

更多信息
Creo Medical Group plc has completed a US$15.7 million equity fundraise
医疗健康

Creo Medical Group plc has completed a US$15.7 million equity fundraise

Creo Medical Group plc, the provider of pioneering endoscopic healthcare solutions to clinicians and healthcare providers across the world, has completed a US$15.7 million (£12.1 million) equity fundraise.

更多信息